BRIEF-Denali Therapeutics Q4 Operating Income USD -129.846 Million

Reuters
28 Feb
BRIEF-Denali <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Q4 Operating Income USD -129.846 Million

Feb 27 (Reuters) - Denali Therapeutics Q4 basic EPS USD -0.67.

  • Q4 net income USD -114.753 million
  • Q4 operating expenses USD 129.846 million
  • Q4 pretax profit USD -114.685 million

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10